TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27438569

Group type: EXPERIMENTAL
Intervention: Smoking Cessation Program (quitters)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 33
Study: 27438938

Group type: EXPERIMENTAL
Intervention: Facial pain location, severity, and interference scores measured using the Brief Pain Inventory Short Form.
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Facial pain location in CRS patients.
Number of subjects: 83
Study: 27439593

Group type: EXPERIMENTAL
Intervention: 16-week supervised exercise program
Number of subjects: 10
Study: 27439618

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET) during a ten-week inpatient program
Number of subjects: 11
Study: 27439667

Group type: EXPERIMENTAL
Intervention: Patients' health beliefs about lifestyle habits
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Spouses' health beliefs about lifestyle habits
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Patients' beliefs regarding supervised exercise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Patients' beliefs regarding medication
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: General agreement between patients and spouses
Number of subjects: 22
Study: 27439710

Group type: EXPERIMENTAL
Intervention: Medtronic Sentrino(®) CGM system
Number of subjects: 20
Study: 27440251

Group type: EXPERIMENTAL
Intervention: Comoestas group (electronic diary with alert system and facilitated communication)
Number of subjects: 663

Group type: COMPARATOR
Intervention: Classic group (paper headache diary)
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Comoestas group
Number of subjects: 663

Group type: COMPARATOR
Intervention: Classic group
Number of subjects: 663
Study: 27440259

Group type: EXPERIMENTAL
Intervention: 20 g LNS-PL/d (118 kcal) containing essential fatty acids and vitamins and minerals until delivery
Number of subjects: 4011

Group type: COMPARATOR
Intervention: 60 mg Fe + 400 μg folic acid/d
Number of subjects: 4011
Study: 27440260

Group type: EXPERIMENTAL
Intervention: Whey protein (Whey-35)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Micellar casein (MCas-35)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Wheat protein hydrolysate (WPH-60)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wheat protein (WPH-35)
Number of subjects: 60
Study: 27440628

Group type: EXPERIMENTAL
Intervention: Preoperative heart rate >96 beats min(-1)
Number of subjects: 15087

Group type: EXPERIMENTAL
Intervention: Preoperative heart rate <60 beats min(-1)
Number of subjects: 15087

Group type: EXPERIMENTAL
Intervention: Predefined binary heart rate thresholds
Number of subjects: 15087
Study: 27440630

Group type: EXPERIMENTAL
Intervention: Covert stroke incidence after non-cardiac surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Major general surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Major orthopaedic surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Major urological or gynaecological surgery
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-risk surgery
Number of subjects: 100
Study: 27440637

Group type: EXPERIMENTAL
Intervention: Long mean distribution time (MDT) and high end-inspiratory flow (EIF)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Change of inspiratory time (TI) from 33% to 15% and postinspiratory pause (TP) from 10% to 28%
Number of subjects: 8

Group type: COMPARATOR
Intervention: Heat and moisture exchanger
Number of subjects: 8
Study: 27440658

Group type: EXPERIMENTAL
Intervention: Parent-administered physical therapy (10 minutes twice a day for 3 weeks from 34 to 36 weeks' PMA)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 153
Study: 27441182

Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA) with Prestige LP Disc
Number of subjects: 280

Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: CDA
Number of subjects: 280

Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 280
Study: 27441564

Group type: EXPERIMENTAL
Intervention: Intervention details not available
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control details not available
Number of subjects: 0
Study: 27442600

Group type: EXPERIMENTAL
Intervention: Bendamustine 40 mg/m², lenalidomide, low-dose dexamethasone
Number of subjects: 15
Study: 27442601

Group type: EXPERIMENTAL
Intervention: Airflow limitation observed in patients with ischemic heart disease
Number of subjects: 3103

Group type: EXPERIMENTAL
Intervention: Airflow limitation
Number of subjects: 3103
Study: 27443429

Group type: EXPERIMENTAL
Intervention: TAVR intervention
Number of subjects: 3687
Study: 27443431

Group type: EXPERIMENTAL
Intervention: Hybrid Coronary Revascularization (HCR)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Multivessel PCI
Number of subjects: 298
Study: 27443634

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CTh)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Healthy Controls (HCs)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Localized CRC without chemotherapy (CTh-)
Number of subjects: 289
Study: 27444203

Group type: EXPERIMENTAL
Intervention: Heterozygous familial hypercholesterolemia (FH) patients
Number of subjects: 4132

Group type: COMPARATOR
Intervention: Unaffected relatives
Number of subjects: 4132
Study: 27445347

Group type: EXPERIMENTAL
Intervention: DOX-Colos (bovine colostrum)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DOX-Form (formula)
Number of subjects: 36

Group type: COMPARATOR
Intervention: SAL-Form (saline + formula)
Number of subjects: 36

Group type: COMPARATOR
Intervention: SAL-Colos (saline + bovine colostrum)
Number of subjects: 36
Study: 27445874

Group type: EXPERIMENTAL
Intervention: iCBIT
Number of subjects: 160
Study: 27445882

Group type: EXPERIMENTAL
Intervention: Exercise intervention (emphasizing self-regulatory strategies for behavior change)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Stress management intervention (coping and relaxation techniques)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Stress management intervention
Number of subjects: 72
Study: 27446211

Group type: EXPERIMENTAL
Intervention: DecisionDx-UM Class 1 results
Number of subjects: 70

Group type: COMPARATOR
Intervention: DecisionDx-UM Class 2 results
Number of subjects: 70

Group type: COMPARATOR
Intervention: Class 2 patients monitoring and referrals
Number of subjects: 70
Study: 27446991

Group type: EXPERIMENTAL
Intervention: xMELP assay with M-score calculation
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: Binary M-score classifier
Number of subjects: 549
Study: 27447788

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Volume-controlled ventilation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both ventilation modes
Number of subjects: 17
Study: 27448285

Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 0
Study: 27449568

Group type: EXPERIMENTAL
Intervention: Stillbirth or neonatal death
Number of subjects: 41348

Group type: EXPERIMENTAL
Intervention: Early postneonatal death
Number of subjects: 41348

Group type: EXPERIMENTAL
Intervention: Stillbirth
Number of subjects: 41348

Group type: EXPERIMENTAL
Intervention: Higher levels of education (≥10 years)
Number of subjects: 41348

Group type: EXPERIMENTAL
Intervention: Lower levels of education (no education)
Number of subjects: 41348

Group type: EXPERIMENTAL
Intervention: Lower levels of education (1-9 years)
Number of subjects: 41348
Study: 27449652

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (six sessions focused on GWG)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual care (PRAMS respondents)
Number of subjects: 230
Study: 27450106

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care therapies
Number of subjects: 0
Study: 27450309

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 48605

Group type: EXPERIMENTAL
Intervention: Histamine-2 Receptor Antagonists (H2RAs)
Number of subjects: 48605
Study: 27450311

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS)
Number of subjects: 28
Study: 27450466

Group type: EXPERIMENTAL
Intervention: Internet-based 8-week mindfulness program
Number of subjects: 90

Group type: COMPARATOR
Intervention: Internet-based 4-week expressive writing program (active control)
Number of subjects: 90
Study: 27450632

Group type: EXPERIMENTAL
Intervention: Atypical depression in probands
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Melancholic depression in probands
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Familial heritability of atypical subtype
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Familial heritability of melancholic subtype
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Melancholic depression
Number of subjects: 457
Study: 27451002

Group type: EXPERIMENTAL
Intervention: Isocaloric fructose restriction
Number of subjects: 37
Study: 27451390

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg intravenously every 2 weeks)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 80
Study: 27452608

Group type: EXPERIMENTAL
Intervention: Gene set of 13 genes
Number of subjects: 204

Group type: COMPARATOR
Intervention: Baseline clinical variables
Number of subjects: 204

Group type: COMPARATOR
Intervention: Clinical and pathological variables
Number of subjects: 204

Group type: COMPARATOR
Intervention: Routine pathological variables
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Predictive gene set
Number of subjects: 204
Study: 27453079

Group type: COMPARATOR
Intervention: Guanfacine (GUAN) 1-3 mg/day
Number of subjects: 207

Group type: COMPARATOR
Intervention: D-methylphenidate extended-release (DMPH) 5-20 mg/day
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Combination of GUAN and DMPH (COMB)
Number of subjects: 207
Study: 27453080

Group type: EXPERIMENTAL
Intervention: d-methylphenidate (DMPH)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: guanfacine (GUAN)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Combination treatment with DMPH and GUAN (COMB)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Nonclinical comparison group (placebo)
Number of subjects: 182
Study: 27453081

Group type: EXPERIMENTAL
Intervention: Guanfacine (GUAN)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: d-Methylphenidate (DMPH)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Combination (COMB)
Number of subjects: 179
Study: 27453127

Group type: EXPERIMENTAL
Intervention: Melody valve implant
Number of subjects: 136
Study: 27453716

Group type: EXPERIMENTAL
Intervention: Carbohydrate-free diet for 72 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total starvation for 72 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard mixed meal diet (control)
Number of subjects: 0
Study: 27453733

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin injections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral antidiabetic drugs (OADs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetes-related distress
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of OADs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-monitoring blood glucose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hurried communication style in the process of care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of insulin injections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adherence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not filling insulin prescription due to associated cost
Number of subjects: 0
Study: 27453734

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS) with minor allele G of ESR1 gene polymorphism (rs9340799)
Number of subjects: 1977

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 1977

Group type: EXPERIMENTAL
Intervention: Interaction of MetS and ESR1 gene polymorphism (rs9340799)
Number of subjects: 1977
Study: 27453775

Group type: EXPERIMENTAL
Intervention: Maternal probiotic supplementation
Number of subjects: 259
Study: 27454930

Group type: EXPERIMENTAL
Intervention: EndoTAG-1 22mg/m2 plus paclitaxel 70mg/m2
Number of subjects: 20
Study: 27455851

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (women without cancer diagnoses)
Number of subjects: 58
Study: 27455960

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention with the Distress Thermometer (DT) plus usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention with the DT plus usual care
Number of subjects: 0
Study: 27456153

Group type: EXPERIMENTAL
Intervention: Circulating tumour cells (CTCs) cultured from blood of patients with advanced metastatic CRC.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CTC culture model
Number of subjects: 0
Study: 27456232

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU) followed by 400 IU daily for 6 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 27456349

Group type: EXPERIMENTAL
Intervention: Community-driven quality improvement initiatives
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: FORGE AHEAD program activities
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Community-level intervention activities
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Program wrap-up activities
Number of subjects: 11
Study: 27456703

Group type: EXPERIMENTAL
Intervention: Extracorporeal CO2 removal (ECCO2R) using a pump-driven veno-venous ECCO2R system (iLA-Activve(®); Novalung, Heilbronn, Germany)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Invasive mechanical ventilation (IMV)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Extracorporeal CO2 removal (ECCO2R)
Number of subjects: 25
Study: 27456710

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for none
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 1-3 months
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 4-12 months
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT) with BED <178.0 Gy2
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT) with BED ≥178.0 Gy2
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Low-dose-rate brachytherapy (LDR-BT) with or without supplemental EBRT and ADT
Number of subjects: 292
Study: 27456841

Group type: EXPERIMENTAL
Intervention: TNFA -308G → A polymorphism (GG homozygotes)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: TNFA -308G → A polymorphism
Number of subjects: 230

Group type: COMPARATOR
Intervention: MECHE cohort (control group)
Number of subjects: 230
Study: 27456845

Group type: EXPERIMENTAL
Intervention: The Healthy Primary School of the Future
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: The Physical Activity School
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 1200
Study: 27457375

Group type: EXPERIMENTAL
Intervention: Triglycerides (TG)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Triglycerides (TG) combined with Total Cholesterol (TC)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Triglycerides (TG) combined with Low-Density Lipoprotein (LDL)
Number of subjects: 455
Study: 27457469

Group type: EXPERIMENTAL
Intervention: Latanoprostene bunod (LBN) ophthalmic solution 0.024%
Number of subjects: 130
Study: 27457512

Group type: EXPERIMENTAL
Intervention: DAPSA remission (REM, ≤4)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Low disease activity (LDA, ≤14)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Moderate disease activity (MDA, ≤28)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: High disease activity (HDA, >28)
Number of subjects: 440

Group type: COMPARATOR
Intervention: TNF inhibitors or placebo (subgroup analysis)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire Disability Index (HAQ)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Physical component scale of the Short Form-36 (PCS)
Number of subjects: 440
Study: 27457584

Group type: EXPERIMENTAL
Intervention: Incidence of AOM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incidence of AOM in Slovenia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breastfeeding status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attendance at school/childcare or presence of allergies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doctor visits due to AOM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic prescription rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hospitalization due to AOM
Number of subjects: 0
Study: 27457707

Group type: EXPERIMENTAL
Intervention: CEP-37250/KHK2804 (0.03-1.0 mg/kg) intravenously once weekly
Number of subjects: 62
Study: 27458003

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (BV) and AVD (adriamycin, vinblastine, and dacarbazine) followed by 30 Gy involved site radiation therapy (ISRT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin (BV) and AVD (adriamycin, vinblastine, and dacarbazine)
Number of subjects: 30
Study: 27459380

Group type: EXPERIMENTAL
Intervention: Prolonged exposure for adolescents (PE-A)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Client-centered therapy (CCT)
Number of subjects: 61
Study: 27459537

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (GLP-1-RA) exenatide for 9 weeks
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (GLP-1-RA) exenatide
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: GLP-1-RA and/or iron chelator deferiprone
Number of subjects: 1
Study: 27460041

Group type: EXPERIMENTAL
Intervention: Continuing medical education (CME)
Number of subjects: 831

Group type: COMPARATOR
Intervention: Reference (non-participating) GPs
Number of subjects: 831
Study: 27460105

Group type: EXPERIMENTAL
Intervention: MMP-3 and MMP-10
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MMP-7 and MMP-8
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: MMP-9
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mild CLE
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Multiple MMPs
Number of subjects: 32
Study: 27460276

Group type: EXPERIMENTAL
Intervention: Patients with AL amyloidosis
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Patients with cardiac amyloidosis
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Patients with cardiac involvement
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Patients ≥65 years
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1226
Study: 27460387

Group type: EXPERIMENTAL
Intervention: EUS-guided pancreatic drainage (EUS-PD)
Number of subjects: 80
Study: 27460442

Group type: EXPERIMENTAL
Intervention: Vemurafenib 960 mg orally twice daily (cohort 1)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Vemurafenib 960 mg orally twice daily (cohort 2)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Vemurafenib (both cohorts)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study: 27460571

Group type: EXPERIMENTAL
Intervention: Rituximab-based chemotherapy (R-chemo)
Number of subjects: 0
Study: 27461213

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 5936
Study: 27461255

Group type: EXPERIMENTAL
Intervention: Induction neoadjuvant chemotherapy (NACT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential chemoradiotherapy (CRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-NACT matrix metalloproteinase-9 levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diarrhea scores
Number of subjects: 0
Study: 27462120

Group type: EXPERIMENTAL
Intervention: Healthy smokers who quit smoking for 12 months
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: COPD smokers who quit smoking for 12 months
Number of subjects: 61

Group type: COMPARATOR
Intervention: Healthy smokers who continued smoking
Number of subjects: 61

Group type: COMPARATOR
Intervention: COPD smokers who continued smoking
Number of subjects: 61
Study: 27462386

Group type: EXPERIMENTAL
Intervention: Calcipotriene/betamethasone topical suspension (once-daily)
Number of subjects: 8
Study: 27462400

Group type: EXPERIMENTAL
Intervention: Ferumoxytol
Number of subjects: 767

Group type: COMPARATOR
Intervention: Iron sucrose
Number of subjects: 767
Study: 27463414

Group type: EXPERIMENTAL
Intervention: ipragliflozin
Number of subjects: 3481
Study: 27463628

Group type: EXPERIMENTAL
Intervention: AcrySof® ReSTOR® SN6AD1
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: AMO Tecnis® ZMB00
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparison of both lenses
Number of subjects: 37
Study: 27463639

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) delivered by nonspecialists
Number of subjects: 0
Study: 27463733

Group type: EXPERIMENTAL
Intervention: Rituximab (two infusions of 1000 mg at month 0 and 6, plus 100 mg methylprednisolone)
Number of subjects: 14
Study: 27464202

Group type: EXPERIMENTAL
Intervention: HMW multimers normalization in patients without aortic regurgitation (137 patients)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: CT-ADP assessment
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: HMW multimers and CT-ADP values at the end of TAVR
Number of subjects: 183
Study: 27464316

Group type: EXPERIMENTAL
Intervention: Presence of Major Depressive Episode (MDE)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Antidepressant use
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory (BDI) scores
Number of subjects: 235

Group type: COMPARATOR
Intervention: Generalized Anxiety Disorder presence
Number of subjects: 235